Polycystic Liver Disease
📧 Sign up to get email alerts when something new happens for Polycystic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Polycystic Liver Disease Registry (UK)
An update on the Polycystic Liver Disease Registry (UK) indicating the study is currently recruiting.
-
CLINICAL_TRIALS other · 2025-12-11Clinical Trial Update: A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD [Phase 2, Phase 3]
This entry provides the status of a Phase 2/Phase 3 trial evaluating Octreotide Subcutaneous Depot for polycystic liver disease, currently A…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
This clinical trial update discusses the development and assessment of the Polycystic Liver Disease Questionnaire (PLD-Q) for patients with …
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease [Phase 2]
Phase 2 trial update evaluating ursodeoxycholic acid as treatment for polycystic liver disease.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: Pasireotide LAR in Severe Polycystic Liver Disease [Phase 2]
Phase 2 clinical trial of pasireotide LAR in severe polycystic liver disease has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Everolimus and LongActing Octreotide Trial in Polycystic Livers [Phase 2]
A Phase 2 trial evaluating the combination of everolimus and long-acting octreotide for polycystic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
The RESOLVE trial, evaluating somatostatin analogues as a volume-reducing treatment for polycystic liver disease, has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease [Phase 2, Phase 3]
A clinical trial update on lanreotide Autogel for symptomatic polycystic liver disease, covering Phase 2 and Phase 3, which has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Polycystic Liver Disease in Kidney Transplant [NA]
A Mayo Clinic-sponsored trial evaluating polycystic liver disease in kidney transplant patients was terminated. Results were posted on 2013-…
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Octreotide in Severe Polycystic Liver Disease [Phase 2, Phase 3]
This clinical trial update reports completion and posted results for phase 2/3 studies of octreotide in severe polycystic liver disease, spo…
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Lanreotide as Treatment of Polycystic Livers [Phase 2, Phase 3]
Phase 2/3 clinical trial of lanreotide for polycystic liver disease has completed, indicating ongoing evaluation for this indication.
-
CLINICAL_TRIALS trial_result · 2008-11-13Clinical Trial Update: Open-Label Extension of LOCKCYST Trial [Phase 2, Phase 3]
This document provides an update on the open-label extension of the LOCKCYST trial spanning Phase 2 and Phase 3. No results or current statu…